国际眼科纵览

• 综述 • 上一篇    下一篇

后发性白内障的表观遗传学研究进展

李华 苑晓勇   

  1. 天津市眼科医院 天津市眼科研究所 眼科学与视觉科学天津市重点实验室 天津医科大学眼科临床学院 300020
  • 收稿日期:2019-08-11 出版日期:2020-02-22 发布日期:2020-02-27
  • 通讯作者: 苑晓勇,Email: yuanxy_cn@hotmail.com E-mail:yuanxy_cn@hotmail.com
  • 基金资助:
    国家自然科学基金(81670817);中国博士后科学基金(2018M641665)

Advancement of epigenetics on posterior capsular opacification

Li Hua, Yuan Xiaoyong   

  1. Tianjin Eye Hospital, Tianjin Eye Institute, Tianjin Key Laboratory of Ophthalmology and Visual Sciences, Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China
  • Received:2019-08-11 Online:2020-02-22 Published:2020-02-27
  • Contact: Yuan Xiaoyong, Email: yuanxy_cn@hotmail.com E-mail:yuanxy_cn@hotmail.com
  • Supported by:
    National Nature Science Foundation of China (81670817); China Postdoctoral Science Foundation (2018M641665)

摘要: 后发性白内障(posterior capsular opacification,PCO)是白内障手术后最常见并发症,其分子机制与基因的特异性表达相关。表观遗传学是不改变DNA序列而实现基因选择性表达和调控可遗传修饰的过程,其主要模式包括DNA甲基化、组蛋白修饰和非编码RNA调节等。体内及体外实验研究发现DNA甲基化抑制剂、组蛋白乙酰化抑制剂以及非编码RNA参与调控PCO发生发展中表型的变化并影响其进程。

Abstract: Posterior capsular opacification (PCO) is the most common complication of cataract surgery, the progression of PCO is closely related with specific gene expression. Epigenetics refers to the heritable changes and genetic modifications without a change in the DNA sequence itself, including aberrant DNA methylation, histone modification patterns and noncoding RNA regulation. In vivo and in vitro studies have found that DNA methyltransferaseinhibitor, histone deacetylaseinhibitor and noncoding RNA regulation are involved in the progression of PCO and its phenotypic changes.